Association and predictive value of sarcopenic obesity for the prognosis of lung cancer patients receiving immune checkpoint inhibitors
SO is an independent prognostic factor for lung cancer patients receiving immunotherapy. Early identification and targeted management of sarcopenic obesity are crucial for optimizing treatment strategies and improving survival outcomes in ICI-treated lung cancer patients.
Authors
- Ke Guan
- Weixiang Wang (ORCID: https://orcid.org/0000-0001-8586-1499)
- Yan Yang (ORCID: https://orcid.org/0000-0001-8146-8040)
- Yan Qiao (ORCID: https://orcid.org/0009-0002-0360-1816)
- Lijun Shen
- Wen Wang
- Yongchun Chen
- Tingting Yang
Institutions
- Tianjin First Center Hospital (CN)
- Henan Provincial People's Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2026-03-11
- DOI
- https://doi.org/10.3389/fnut.2026.1687912
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chinese Society of Clinical Oncology